TTK Healthcare Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 14.51% vs 5.14% in Mar 2025

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is 34.74% vs -11.60% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -8.16% vs -3.30% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is -28.89% vs -3.23% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of TTK Healthcare With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

217.98

740.37

-522.39

-70.56%

Other Operating Income

0.00

Total Operating income

217.98

740.37

-522.39

-70.56%

Raw Material Cost

51.49

474.53

-423.04

-89.15%

Purchase of Finished goods

53.30

3.99

49.31

1,235.84%

(Increase) / Decrease In Stocks

1.41

8.46

-7.05

-83.33%

Employee Cost

40.99

63.92

-22.93

-35.87%

Power Cost

0.00

Manufacturing Expenses

0.00

-0.01

0.01

100.00%

Selling and Distribution Expenses

0.00

Other Expenses

59.76

86.57

-26.81

-30.97%

Total Expenditure (Excl Depreciation)

206.95

637.46

-430.51

-67.54%

Operating Profit (PBDIT) excl Other Income

11.03

102.91

-91.88

-89.28%

Other Income

17.77

50.92

-33.15

-65.10%

Operating Profit (PBDIT)

28.80

153.83

-125.03

-81.28%

Interest

0.64

7.68

-7.04

-91.67%

Exceptional Items

3.50

0.00

3.50

Gross Profit (PBDT)

31.66

146.15

-114.49

-78.34%

Depreciation

2.14

25.36

-23.22

-91.56%

Profit Before Tax

29.53

120.79

-91.26

-75.55%

Tax

7.76

30.26

-22.50

-74.36%

Provisions and contingencies

0.00

Profit After Tax

21.76

90.53

-68.77

-75.96%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

21.76

90.53

-68.77

-75.96%

Equity Capital

14.13

171.00

-156.87

-91.74%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

15.40

5.29

10.11

191.12%

Diluted Earnings per share

15.40

5.30

10.10

190.57%

Operating Profit Margin (Excl OI)

5.06%

13.90%

0.00

-8.84%

Gross Profit Margin

14.52%

19.74%

0.00

-5.22%

PAT Margin

9.98%

12.23%

0.00

-2.25%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 217.98 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 4.15% vs 2.81% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 14.51% vs 5.14% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 21.76 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 106.65% vs -48.36% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 34.74% vs -11.60% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 11.03 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 54.48% vs 33.96% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -8.16% vs -3.30% in Mar 2025

Quarterly - Interest

Interest 0.64 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -5.88% vs -19.05% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -28.89% vs -3.23% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 5.06%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025